TY - JOUR KW - Amino Acid Sequence KW - Animals KW - Antibodies, Monoclonal KW - Antigens, Bacterial KW - Bacterial Proteins KW - Epitopes, T-Lymphocyte KW - HLA Antigens KW - Histocompatibility Testing KW - Humans KW - Immunization KW - Immunophenotyping KW - leprosy KW - Lymphocyte Activation KW - Molecular Sequence Data KW - Mycobacterium leprae KW - Peptides KW - Recombinant Fusion Proteins KW - T-Lymphocytes AU - Oftung F AU - Lundin K E AU - Meloen R AU - Mustafa A S AB -
We have in this work mapped epitopes and HLA molecules used in human T cell recognition of the Mycobacterium leprae LSR protein antigen. HLA typed healthy subjects immunized with heat killed M. leprae were used as donors to establish antigen reactive CD4+ T cell lines which were screened for proliferative responses against overlapping synthetic peptides covering the C-terminal part of the antigen sequence. By using this approach we were able to identify two epitope regions represented by peptide 2 (aa 29-40) and peptide 6 (aa 49-60), of which the former was mapped in detail by defining the N- and C-terminal amino acid positions necessary for T cell recognition of the core epitope. MHC restriction analysis showed that peptide 2 was presented to T cells by allogeneic cells coexpressing HLA-DR4 and DRw53 or DR7 and DRw53. In contrast, peptide 6 was presented to T cells only in the context of HLA-DR5 molecules. In conclusion, the M. leprae LSR protein antigen can be recognized by human T cells in the context of multiple HLA-DR molecules, of which none are reported to be associated with the susceptibility to develop leprosy. The results obtained are in support of using the LSR antigen in subunit vaccine design.
BT - FEMS immunology and medical microbiology C1 - http://www.ncbi.nlm.nih.gov/pubmed/10378414?dopt=Abstract DA - 1999 Jun DO - 10.1111/j.1574-695X.1999.tb01276.x IS - 2 J2 - FEMS Immunol. Med. Microbiol. LA - eng N2 -We have in this work mapped epitopes and HLA molecules used in human T cell recognition of the Mycobacterium leprae LSR protein antigen. HLA typed healthy subjects immunized with heat killed M. leprae were used as donors to establish antigen reactive CD4+ T cell lines which were screened for proliferative responses against overlapping synthetic peptides covering the C-terminal part of the antigen sequence. By using this approach we were able to identify two epitope regions represented by peptide 2 (aa 29-40) and peptide 6 (aa 49-60), of which the former was mapped in detail by defining the N- and C-terminal amino acid positions necessary for T cell recognition of the core epitope. MHC restriction analysis showed that peptide 2 was presented to T cells by allogeneic cells coexpressing HLA-DR4 and DRw53 or DR7 and DRw53. In contrast, peptide 6 was presented to T cells only in the context of HLA-DR5 molecules. In conclusion, the M. leprae LSR protein antigen can be recognized by human T cells in the context of multiple HLA-DR molecules, of which none are reported to be associated with the susceptibility to develop leprosy. The results obtained are in support of using the LSR antigen in subunit vaccine design.
PY - 1999 SP - 151 EP - 9 T2 - FEMS immunology and medical microbiology TI - Human T cell recognition of the Mycobacterium leprae LSR antigen: epitopes and HLA restriction. VL - 24 SN - 0928-8244 ER -